Brief: Athenex Announces Collaboration With Merck To Evaluate Oraxol Plus Keytruda In Patients With NSCLC
16/05/2022 13:05
May 16 (Reuters) - Athenex Inc ATNX.O :
* ATHENEX ANNOUNCES CLINICAL COLLABORATION WITH MERCK TO
EVALUATE
ORAXOL PLUS KEYTRUDA® (PEMBROLIZUMAB) IN PATIENTS WITH NON-SMALL
CELL LUNG CANCER (NSCLC)
Source text for Eikon: ID:nGNX6s8zLd
Further company coverage: ATNX.O
((Reuters.Briefs@thomsonreuters.com;))